View in EDS HTML Full Text PDF Full Text

Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.

Saved in:
Bibliographic Details
Title: Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
Authors: Agiro A; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com., An A; University of California Irvine, Irvine, CA, 92697, USA., Cook EE; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Mu F; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Chen J; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Desai P; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA., Oluwatosin Y; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA., Pollack CV Jr; University of Mississippi, Jackson, MS, 38677, USA.
Source: Advances in therapy [Adv Ther] 2023 Jun; Vol. 40 (6), pp. 2886-2901. Date of Electronic Publication: 2023 May 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37140706
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agiro+A%22">Agiro A</searchLink>; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22An+A%22">An A</searchLink>; University of California Irvine, Irvine, CA, 92697, USA.<br /><searchLink fieldCode="AU" term="%22Cook+EE%22">Cook EE</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Mu+F%22">Mu F</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Desai+P%22">Desai P</searchLink>; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA.<br /><searchLink fieldCode="AU" term="%22Oluwatosin+Y%22">Oluwatosin Y</searchLink>; AstraZeneca, US Medical Affairs, 1800 Concord Pike, Wilmington, DE, 19850, USA.<br /><searchLink fieldCode="AU" term="%22Pollack+CV+Jr%22">Pollack CV Jr</searchLink>; University of Mississippi, Jackson, MS, 38677, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2023 Jun; Vol. 40 (6), pp. 2886-2901. <i>Date of Electronic Publication: </i>2023 May 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37140706
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-023-02518-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2886
    Titles:
      – TitleFull: Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agiro A
      – PersonEntity:
          Name:
            NameFull: An A
      – PersonEntity:
          Name:
            NameFull: Cook EE
      – PersonEntity:
          Name:
            NameFull: Mu F
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Desai P
      – PersonEntity:
          Name:
            NameFull: Oluwatosin Y
      – PersonEntity:
          Name:
            NameFull: Pollack CV Jr
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1